Serum N-terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect

European Journal of Heart Failure

Volumn 2, Issue 2, 2000, Pages 161-165

  Iivainen, Tiina E ^a   Groundstroem, Kaj W E ^a   Lahtela, Jorma T ^a   Talvensaari, Taisto J ^a   Pasternack, Amos ^a   Uusitalo, Arto ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Atrial septal defect; Congenital heart defect; Haemodynamics; Heart; Natriuretic peptide; Surgery

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADULT; AGING; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; CARDIAC SURGICAL PROCEDURES; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; REGRESSION ANALYSIS;

EID: 0034125975     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(00)00076-3     Document Type: Article

References (24)

1. Samanek M., Slavik Z., Zborilova B., Hrobonova V., Voriskova M., Skovranek J. Prevalence, treatment, and outcome of heart disease in live-born children: a prospective analysis of 91,823 live-born children. Pediatr Cardiol. 10:1989;205-211.
2. Seldon W.A., Rubinstein C., Fraser A.A. The incidence of atrial septal defect in adults. Br Heart J. 24:1962;557-560.
3. Espino-Vela J., Alvarado-Toro A. Natural history of atrial septal defect. Cardiovasc Clin. 2:1971;103-125.
4. Murphy J.G., Gersh B.J., McGoon M.D. et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med. 323:1990;1645-1650.
5. Siltanen P. Atrial septal defect of secundum type in adults. Acta Med Scand 1968;497(Suppl):1-151.
6. Huysmans H.A., Vrakking M., van Boven W.J.P. Late follow-up after surgical correction of atrial septal defect of the secundum type. Z Kardiol. 7(Suppl):1989;43-45.
7. Meijboom F., Hess J., Szatmari A. et al. Long-term follow-up (9 to 20 years) after surgical closure of atrial septal defect at a young age. Am J Cardiol. 72:1993;1431-1434.
8. Chen H.H., Burnett J.C. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Phys. 111:1999;406-416.
9. Bonow R.O. New insights into the cardiac natriuretic peptides. Circulation. 93:1996;1946-1950.
10. Uchiyama M., Satokata I., Sakai K. Plasma atrial natriuretic peptide in congenital heart disease. Acta Paediatr. 76:1987;669-670.
11. Kikuchi K., Nishioka K., Ueda T. et al. Relationship between plasma atrial natriuretic polypeptide concentration and hemodynamic measurements in children with congenital heart diseases. J Pediatr. 111:1987;335-342.
12. Matsuoka S., Kurahashi Y., Miki Y. et al. Plasma atrial natriuretic peptide in patients with congenital heart diseases. Pediatrics. 82:1988;639-643.
13. Holmström H., Thaulow E., Stokke O., Lindberg H., Hall C. Serum N-terminal proatrial natriuretic factor in children with congenital heart disease. Eur Heart J. 17:1996;1737-1746.
14. Lang R.E., Dietz R., Merkel A., Unger T., Ruskoaho H., Ganten D. Plasma atrial natriuretic peptide values in cardiac disease. J Hypertens. 4(Suppl 2):1986;119-123.
15. Guidelines Sub-Committee 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens. 11:1993;905-918.
16. Tikkanen I., Helenius T., Heinänen T., Soveri P. N-terminal atrial natriuretic peptide (ANP-N) in heart failure [Abstr.]. Scand J Clin Lab Invest. 55(Suppl 223):1995;645.
17. The declaration of Helsinki. Br Med J. II:1964;177.
18. Fyhrquist F., Tikkanen I. Atrial natriuretic peptide in congestive heart failure. Am J Cardiol. 62:1988;20A-24A.
19. Iivanainen A.M., Tikkanen I., Tilvis R., Heikkilä J., Helenius T., Kupari M. Associations between atrial natriuretic peptides, echocardiographic findings and mortality in an elderly population sample. J Intern Med. 241:1997;261-268.
20. Hall C., Rouleau J.L., Moyè L. et al. N-Terminal proatrial natriuretic factor. an independent predictor of long-term prognosis after myocardial infarction. Circulation. 89:1994;1934-1942.
21. Bidlingmaier J.W., Döhlemann C., Kuhnle U., Strom T., Lang R.E. Comparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseases. Pediatr Res. 20:1986;1328-1331.
22. Kindelan A.A., Navero J.L.P., De La Rosa I.I., Ruiz M.C., Lopez P.M., Lezcano A.R. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease. Crit Care Med. 22:1994;1754-1761.
23. Agnoletti G., Scotti C., Panzali A.F. et al. Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgery. Eur J Cardio-thorac Surg. 7:1993;533-539.
24. Montorsi P., Tonolo G., Polonia J., Hepburn D., Richards M. Correlates of plasma atrial natriuretic factor in health and hypertension. Hypertension. 10:1987;570-576.